Welcome to LookChem.com Sign In|Join Free

CAS

  • or
C26H21N5O2S is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1433991-77-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1433991-77-5 Structure
  • Basic information

    1. Product Name: C26H21N5O2S
    2. Synonyms: C26H21N5O2S
    3. CAS NO:1433991-77-5
    4. Molecular Formula:
    5. Molecular Weight: 467.551
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1433991-77-5.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C26H21N5O2S(CAS DataBase Reference)
    10. NIST Chemistry Reference: C26H21N5O2S(1433991-77-5)
    11. EPA Substance Registry System: C26H21N5O2S(1433991-77-5)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1433991-77-5(Hazardous Substances Data)

1433991-77-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1433991-77-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,3,3,9,9 and 1 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1433991-77:
(9*1)+(8*4)+(7*3)+(6*3)+(5*9)+(4*9)+(3*1)+(2*7)+(1*7)=185
185 % 10 = 5
So 1433991-77-5 is a valid CAS Registry Number.

1433991-77-5Downstream Products

1433991-77-5Relevant articles and documents

SEVEN-MEMBERED SULFONAMIDES AS MODULATORS OF RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ, NR1F3)

-

Page/Page column 47, (2013/05/22)

The invention provides modulators for the orphan nuclear receptor RORγ and methods for treating RORγ mediated diseases by administration of these novel RORγ modulators to a human or a mammal in need thereof. Specifically, the present invention provides compounds of Formula (1) and the enantiomers, diastereomers, tautomers, solvates and pharmaceutically acceptable salts thereof as well as pharmaceutical compositions comprising said compounds as an active ingredient.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1433991-77-5